We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+4.57%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.79B
AUM Growth
-$730M
Cap. Flow
-$661M
Cap. Flow %
-23.73%
Top 10 Hldgs %
39.61%
Holding
2,225
New
423
Increased
362
Reduced
424
Closed
673

Top Buys

Rank Stock Value
1
KAHC
KKR Acquisition Holdings I Corp.
KAHC
+$30.7M
2
TWTR
Twitter, Inc.
TWTR
+$23.5M
3
BABA icon
Alibaba
BABA
+$18.2M
4
DRE
Duke Realty Corp.
DRE
+$15.4M
5
SCRM
Screaming Eagle Acquisition Corp. Class A Ordinary Shares
SCRM
+$14.5M

Top Sells

Rank Stock Value
1
LMT icon
Lockheed Martin
LMT
+$83M
2
KAHC.U
KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant
KAHC.U
+$43.2M
3
CUTR
Cutera, Inc.
CUTR
+$40.6M
4
PH icon
Parker-Hannifin
PH
+$26.1M
5
SCRMU
Screaming Eagle Acquisition Corp. Unit
SCRMU
+$18.6M

Sector Composition

Rank Sector Weight
1 Financials 17.63%
2 Technology 11.49%
3 Industrials 6.96%
4 Consumer Discretionary 5.91%
5 Healthcare 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SXC icon
1126
SunCoke Energy
SXC
$789M
$116K ﹤0.01%
+20,000
New +$134K
SMRT icon
1127
SmartRent
SMRT
$274M
$115K ﹤0.01%
50,650
+23,121
+84% +$91.2K
GHIXW
1128
DELISTED
Gores Holdings IX, Inc. Warrant
GHIXW
$115K ﹤0.01%
333,333
– –
DNA icon
1129
CALL
Ginkgo Bioworks
DNA
$508M
$114K ﹤0.01%
+4,350
New +$518K
SCRMW
1130
DELISTED
Screaming Eagle Acquisition Corp. Warrant
SCRMW
$110K ﹤0.01%
500,000
-16,666
-3% -$4.63K
KRO icon
1131
KRONOS Worldwide
KRO
$971M
$109K ﹤0.01%
+11,677
New +$171K
DOYU
1132
DouYu International Holdings
DOYU
$139M
$104K ﹤0.01%
+10,430
New +$132K
SPRY icon
1133
ARS Pharmaceuticals
SPRY
$584M
$104K ﹤0.01%
19,694
-22,006
-53% -$108K
LENZ
1134
LENZ Therapeutics
LENZ
$162M
$104K ﹤0.01%
4,700
+1,206
+35% +$28.7K
EMKR
1135
DELISTED
Emcore Corp
EMKR
$104K ﹤0.01%
6,238
-24,019
-79% -$642K
ABUS icon
1136
Arbutus Biopharma
ABUS
$930M
$103K ﹤0.01%
53,877
-14,688
-21% -$34.6K
CSTA
1137
DELISTED
Constellation Acquisition Corp I
CSTA
$103K ﹤0.01%
10,385
– –
WNEB icon
1138
Western New England Bancorp
WNEB
$280M
$101K ﹤0.01%
+12,415
New +$103K
IVCBU
1139
DELISTED
Investcorp Europe Acquisition Corp I Unit
IVCBU
$101K ﹤0.01%
10,000
– –
ADER
1140
DELISTED
26 Capital Acquisition Corp
ADER
$100K ﹤0.01%
10,171
– –
CRECU
1141
DELISTED
Crescera Capital Acquisition Corp Unit
CRECU
$100K ﹤0.01%
10,000
-50,000
-83% -$500K
JBLU icon
1142
JetBlue
JBLU
$2.19B
$99K ﹤0.01%
15,000
-8,834
-37% -$71.9K
PTRS
1143
DELISTED
Partners Bancorp Common Stock
PTRS
$98K ﹤0.01%
+11,040
New +$103K
RAD
1144
DELISTED
Rite Aid Corporation
RAD
$98K ﹤0.01%
19,704
+2,182
+12% +$16.9K
FZT
1145
DELISTED
FAST Acquisition Corp. II
FZT
$98K ﹤0.01%
10,000
-20,000
-67% -$196K
FSTX
1146
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$98K ﹤0.01%
19,088
-17,190
-47% -$108K
AG icon
1147
First Majestic Silver
AG
$9.29B
$96K ﹤0.01%
+12,605
New +$94K
MTW icon
1148
Manitowoc
MTW
$696M
$96K ﹤0.01%
12,400
+1,970
+19% +$19.9K
SCS
1149
DELISTED
Steelcase
SCS
$96K ﹤0.01%
+14,684
New +$157K
BRCC icon
1150
BRC Inc
BRCC
$217M
$90K ﹤0.01%
11,600
-59,262
-84% -$536K
44 45
46
47 48

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Prelude Capital Management held 2,225 positions worth $2.79B, down 21% from $3.52B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Prelude Capital Management withdrew a net $661M in Q3 2022, closing 673 positions and reducing 424 holdings. Its most notable exit was KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant, an estimated $43.2M position sold in full.

By sector, the portfolio is most concentrated in Financials at 18% of assets, up from 11% a quarter earlier, followed by Technology and Industrials.

Against the trend, Prelude Capital Management opened a new position in KKR Acquisition Holdings I Corp. worth $30.7M.

  • Prelude Capital Management's largest Q3 2022 buy was KKR Acquisition Holdings I Corp.: 3,123,025 shares worth $30.7M.
  • Prelude Capital Management added most to Twitter, Inc. in Q3 2022, an estimated $23.5M increase.
  • Prelude Capital Management's biggest Q3 2022 reduction was Lockheed Martin, cutting an estimated $83M.
  • Prelude Capital Management fully exited KKR Acquisition Holdings I Corp. Units, each consisting of one share of Class A Common Stock and one-fourth of one redeemable warrant in Q3 2022, selling an estimated $43.2M.
  • Prelude Capital Management's ten largest holdings make up 40% of its $2.79B portfolio in Q3 2022.
  • Prelude Capital Management opened 423 new positions and closed 673 in Q3 2022.
  • Prelude Capital Management's portfolio value fell 21% quarter-over-quarter to $2.79B.

Based on Prelude Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.